Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 8/2009

01-10-2009

Somatization is associated with physical health-related quality of life independent of anxiety and depression in cancer, glaucoma and rheumatological disorders

Auteurs: Thomas Hyphantis, Barbara Tomenson, Vassiliki Paika, Augoustina Almyroudi, Chrisavgi Pappa, Niki Tsifetaki, Paraskevi V. Voulgari, Alexandros A. Drosos, Nicholas Pavlidis, Francis Creed

Gepubliceerd in: Quality of Life Research | Uitgave 8/2009

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

To test the relative importance of anxiety, depression and somatization as correlates of physical health-related quality of life (HRQOL) in several chronic physical disorders.

Methods

In a cross-sectional study of patients with colorectal cancer (N = 162), glaucoma (N = 100), rheumatoid arthritis (N = 168), systemic sclerosis (N = 56) and systemic lupus erythematosus (N = 56), we assessed specific disease severity and used the Symptom Distress Checklist (SCL-90) for psychologic dimensions. Outcome was assessed with the WHO Quality of Life Instrument, Short Form using hierarchical regression to determine independent correlates of HRQOL.

Results

After adjustment for demographic features, stage of cancer and pain (final models), the SCL-90 somatization score was the only psychologic distress covariate significantly correlated to physical HRQOL in all diseases (Betas between −0.33 and −0.49) except in systemic sclerosis and scleroderma, where depression was also a correlate. In glaucoma patients, the SCL-90 somatization score was the only significant covariate for physical HRQOL in the final model.

Conclusions

Since reported number of bodily symptoms is both associated with physical HRQOL and treatable in its own right, our findings suggest a possible new avenue to improve the HRQOL in patients with chronic physical disease. Whether this offers greater benefit than treatments for anxiety and depression needs further research.
vorige artikel Predictive value of serial measurements of quality of life on all-cause mortality in prostate cancer patients: data from CaPSURE™ (cancer of the prostate strategic urologic research endeavor) database
volgende artikel How sharp is the short QuickDASH? A refined content and validity analysis of the short form of the disabilities of the shoulder, arm and hand questionnaire in the strata of symptoms and function and specific joint conditions
Literatuur
1.
Kroenke, K., Spitzer, R. L., DeGruy, F. V., 3rd, Hahn, S. R., Linzer, M., Williams, J. B., et al. (1997). Multisomatoform disorder. An alternative to undifferentiated somatoform disorder for the somatizing patient in primary care. Archives of General Psychiatry, 54(4), 352–358.PubMed
2.
Feder, A., Olfson, M., Gameroff, M., Fuentes, M., Shea, S., Lantigua, R. A., et al. (2001). Medically unexplained symptoms in an urban general medicine practice. Psychosomatics, 42(3), 261–268.PubMedCrossRef
3.
Koch, H., van Bokhoven, M. A., ter Riet, G., van der Weijden, T., Dinant, G. J., & Bindels, P. J. (2007). Demographic characteristics and quality of life of patients with unexplained complaints: A descriptive study in general practice. Quality of Life Research, 16(9), 1483–1489.PubMedCrossRef
4.
Jackson, J., Fiddler, M., Kapur, N., Wells, A., Tomenson, B., & Creed, F. (2006). Number of bodily symptoms predicts outcome more accurately than health anxiety in patients attending neurology, cardiology, and gastroenterology clinics. Journal of Psychosomatic Research, 60(4), 357–363.PubMedCrossRef
5.
Kroenke, K., Spitzer, R. L., & Williams, J. B. (2002). The PHQ-15: Validity of a new measure for evaluating the severity of somatic symptoms. Psychosomatic Medicine, 64, 258–266.PubMed
6.
Barsky, A. J., Orav, E. J., & Bates, D. W. (2005). Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Archives of General Psychiatry, 62, 903–910.PubMedCrossRef
7.
Derogatis, L. R. (1994). SCL-90-R: Administration, scoring, and procedure manual (3rd ed.). Minneapolis, MN: National Computer Systems.
8.
Creed, F., Tomenson, B., Guthrie, E., Ratcliffe, J., Fernandes, L., Read, N., et al. (2008). The relationship between somatization and outcome in patients with severe irritable bowel syndrome. Journal of Psychosomatic Research, 64(6), 613–620.PubMedCrossRef
9.
Skarstein, J., Aass, N., Fosså, S. D., Skovlund, E., & Dahl, A. A. (2000). Anxiety and depression in cancer patients: Relation between the hospital anxiety and depression scale and the European organization for research and treatment of cancer core quality of life questionnaire. Journal of Psychosomatic Research, 49(1), 27–34.PubMedCrossRef
10.
Stark, D., Kiely, M., Smith, A., Velikova, G., House, A., & Selby, P. (2002). Anxiety disorders in cancer patients: Their nature, associations, and relation to quality of life. Journal of Clinical Oncology, 20(14), 3137–3148.PubMedCrossRef
11.
Smith, E. M., Gomm, S. A., & Dickens, C. M. (2003). Assessing the independent contribution to quality of life from anxiety and depression in patients with advanced cancer. Palliative Medicine, 17(6), 509–513.PubMedCrossRef
12.
Tsunoda, A., Nakao, K., Hiratsuka, K., Yasuda, N., Shibusawa, M., & Kusano, M. (2005). Anxiety, depression and quality of life in colorectal cancer patients. International Journal of Clinical Oncology, 10(6), 411–417.PubMedCrossRef
13.
Lehto, U. S., Ojanen, M., & Kellokumpu-Lehtinen, P. (2005). Predictors of quality of life in newly diagnosed melanoma and breast cancer patients. Annals of Oncology, 16(5), 805–816.PubMedCrossRef
14.
Chaturvedi, S. K., & Maguire, G. P. (1998). Persistent somatization in cancer: A controlled follow-up study. Journal of Psychosomatic Research, 45(3), 249–256.PubMedCrossRef
15.
Chaturvedi, S. K., Maguire., G. P., & Somashekar, B. S. (2006). Somatization in cancer. International Review of Psychiatry, 18(1), 49–54.PubMedCrossRef
16.
Andritsch, E., Dietmaier, G., Hofmann, G., Zloklikovits, S., & Samonigg, H. (2007). Global quality of life and its potential predictors in breast cancer patients: An exploratory study. Supportive Care in Cancer, 15(1), 21–30.PubMedCrossRef
17.
Altangerel, U., Spaeth, G. L., & Rhee, D. J. (2003). Visual function, disability, and psychological impact of glaucoma. Current Opinion in Ophthalmology, 14(2), 100–105.PubMedCrossRef
18.
Jampel, H. D., Frick, K. D., Janz, N. K., Wren, P. A., Musch, D. C., Rimal, R., et al. (2007). CIGTS study group. Depression and mood indicators in newly diagnosed glaucoma patients. American Journal of Ophthalmology, 144(2), 238–244.PubMedCrossRef
19.
Pappa, C., Hyphantis, T., Pappa, S., Aspiotis, M., Stefaniotou, M., Kitsos, G., et al. (2006). Psychiatric manifestations and personality traits associated with compliance with glaucoma treatment. Journal of Psychosomatic Research, 61(5), 609–617.PubMedCrossRef
20.
Jayawant, S. S., Bhosle, M. J., Anderson, R. T., & Balkrishnan, R. (2007). Depressive symptomatology, medication persistence, and associated healthcare costs in older adults with glaucoma. Journal of Glaucoma, 16(6), 513–520.PubMedCrossRef
21.
Escalante, A., & Del Rincón, I. (2002). The disablement process in rheumatoid arthritis. Arthritis and Rheumatism, 47(3), 333–342.PubMedCrossRef
22.
Bazzichi, L., Maser, J., Piccinni, A., Rucci, P., Del Debbio, A., Vivarelli, L., et al. (2005). Quality of life in rheumatoid arthritis: Impact of disability and lifetime depressive spectrum symptomatology. Clinical and Experimental Rheumatology, 23(6), 783–788.PubMed
23.
Danieli, E., Airo, P., Bettoni, L., Cinquini, M., Antonioli, Ch., Cavazzana, I., et al. (2005). Health-related quality of life measured by the Short Form 36 (SF 36) in systemic sclerosis: Correlations with indexes of disease activity and severity, disability and depressive symptoms. Clinical Rheumatology, 24, 48–54.PubMedCrossRef
24.
Rupp, I., Boshuizen, H. C., Dinant, H. J., Jacobi, C. E., & van den Bos, G. A. (2006). Disability and health-related quality of life among patients with rheumatoid arthritis: Association with radiographic joint damage, disease activity, pain, and depressive symptoms. Scandinavian Journal of Rheumatology, 35(3), 175–181.PubMedCrossRef
25.
Hyphantis, T. N., Tsifetaki, N., Siafaka, V., Voulgari, P. V., Pappa, C., Bai, M., et al. (2007). The impact of psychological functioning upon systemic sclerosis patients’ quality of life. Seminars in Arthritis and Rheumatism, 37, 81–92.PubMedCrossRef
26.
Guthrie, E., Jackson, J., Shaffer, J., Thompson, D., Tomenson, B., & Creed, F. (2002). Psychological disorder and severity inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn’s disease. American Journal of Gastroenterology, 97, 1994–1999.PubMedCrossRef
27.
Sainsbury, A., & Heatley, R. V. (2005). Review article: Psychosocial factors in the quality of life of patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 21(5), 499–508.CrossRef
28.
Vidal, A., Gómez-Gil, E., Sans, M., Portella, M. J., Salamero, M., Piqué, J. M., et al. (2008). Health-related quality of life in inflammatory bowel disease patients: The role of psychopathology and personality. Inflammatory Bowel Disease., 14(7), 977–983.CrossRef
29.
Hyphantis, T., Tomenson, B., Bai, M., Tsianos, E., Mavreas, V., & Creed, F. (2009). Psychological distress, somatization and defense mechanisms associated with quality of life in inflammatory bowel disease patients. Digestive Diseases and Sciences. doi:10.​1007/​s10620-009-0762-z.
30.
American Joint Committee on Cancer. AJCC Staging Manual ed 6. (2002). Colon and rectum. Philadelphia: Lippincott- Raven Publishers.
31.
Compton, C. C., Fielding, L. P., Burgart, L. J., et al. (2000). Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement, 1999. Archives of Pathology and Laboratory Medicine, 124(7), 979.PubMed
32.
American Rheumatism Association Diagnostic and Therapeutic Committee. (1980). Subcommittee for scleroderma criteria: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis and Rheumatism, 23, 581–590.CrossRef
33.
Arnett, F. C., Edworthy, S. M., Bloch, D. A., McShane, D. J., Fries, J. F., Cooper, N. S., et al. (1988). The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism, 31(3), 315–324.PubMedCrossRef
34.
Hochberg, M. C. (1997). Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism, 40(9), 1725.PubMedCrossRef
35.
Aasman, P., & Heijl, A. (1992). Evaluation of methods for automated hemifield analysis in perimetry. Archives of Ophthalmology, 110, 812–819.
36.
Prevoo, M. L., van’t Hof, M. A., Kuper, H. H., et al. (1995). Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longtudinal study of patients with rheumatoid arthritis. Arthritis and Rheumatism, 38, 44–48.PubMedCrossRef
37.
Bruce, B., & Fries, J. (2003). The Stanford health assessment questionnaire (HAQ): A review of its history, issues, progress, and documentation. Journal of Rheumatology, 30(1), 167–178.PubMed
38.
Committee on Prognosis Studies. (1986). Prognosis studies in SLE: An activity index. Arthritis and Rheumatism, 29(4), 93.
39.
Bombardier, C., Gladman, D. D., Urowitz, M. B., Caron, D., Chang, C. H., & the Committee on Prognosis Studies in SLE. (1992). Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis and Rheumatism, 35, 630–640.PubMedCrossRef
40.
Clements, P., Lachenbruch, P., Siebold, J., White, B., Weiner, S., Martin, R., et al. (1995). Inter and intraobserver variability of total skin thickness score (Modified Rodnan TSS) in systemic sclerosis. Journal of Rheumatology, 22, 1281–1285.PubMed
41.
Matucci-Cericic, M., D’ Angelo, S., Denton, C. P., Vlachoyiannopoulos, P., & Silver, R. (2003). Assessment of lung involvement. Clinical and Experimental Rheumatology, 21(29), 19–23.
42.
Clements, P. J., Becvar, R., Drosos, A. A., Ghattas, L., & Gabrielli, A. (2003). Assessment of gastrointestinal involvement. Clinical and Experimental Rheumatology, 21(29), 15–18.
43.
Steen, V. D., Mayes, M. D., & Merkel, P. A. (2003). Assessment of kidney involvement. Clinical and Experimental Rheumatology, 21(29), 29–31.
44.
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40, 373–383.PubMedCrossRef
45.
De Groot, V., Beckerman, H., Lankhorst, G. J., & Bouter, L. M. (2003). How to measure comorbidity. A critical review of available methods. Journal of Clinical Epidemiology, 56, 221–229.PubMedCrossRef
46.
Recklitis, C. J., Licht, I., Ford, J., Oeffinger, K., & Diller, L. (2007). Screening adult survivors of childhood cancer with the distress thermometer: A comparison with the SCL-90-R. Psychooncology, 16(11), 1046–1049.PubMedCrossRef
47.
Parker, J. C., Buckelew, S. P., Smarr, K. L., Buescher, K. L., Beck, N. C., Frank, R. G., et al. (1990). Psychological screening in rheumatoid arthritis. Journal of Rheumatology, 17, 1016–1021.PubMed
48.
Donias, S., Karastergiou, A., & Manos, N. (1991). Standardization of the symptom checklist-90-R rating scale in a Greek population (in Greek with English abstract). Psychiatriki, 2, 42–48.
49.
WHOQOL Group. (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychological Medicine, 28(3), 551–558.CrossRef
50.
Skevington, S. M., Lotfy, M., O’Connell, K. A., & WHOQOL Group. (2004). The World Health Organization’s WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial. A report from the WHOQOL group. Quality of Life Research, 13(2), 299–310.PubMedCrossRef
51.
Taylor, W. J., Myers, J., Simpson, R. T., McPherson, K. M., & Weatherall, M. (2004). Quality of life of people with rheumatoid arthritis as measured by the World Health Organization Quality of Life Instrument, short form (WHOQOL-BREF): Score distributions and psychometric properties. Arthritis and Rheumatism, 51(3), 350–357.PubMedCrossRef
52.
Carter, G., Lewin, T., Rashid, G., Adams, C., & Clover, K. (2008). Computerised assessment of quality of life in oncology patients and carers. Psychooncology, 17(1), 26–33.PubMedCrossRef
53.
Ginieri-Coccossis, M., Triantafillou, E., Antonopoulou, V., Tomaras, B., & Christodoulou, G. (2001). Quality of life in relation to WHOQOL-100 questionnaire (in Greek). Athens: Beta Medical Arts.
54.
Altman, D. G. (1991). Practical statistics for medical research. London: Chapman and Hall.
55.
Miles, J., & Shevlin, M. (2003). Applying regression and correlation (pp. 165–191). London: Sage.
56.
Creed, F. H., & Dickens, C. (2007). Depression in the medically ill. In A. Steptoe (Ed.), Depression and physical illness (pp. 3–18). Cambridge: Cambridge University Press.
57.
Katon, W., Lin, E. H., & Kroenke, K. (2007). The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. General Hospital Psychiatry, 29(2), 147–155.PubMedCrossRef
58.
Duddu, V., Husain, N., & Dickens, C. (2008). Medically unexplained presentations and quality of life: A study of a predominantly South Asian primary care population in England. Journal of Psychosomatic Research, 65(4), 311–317.PubMedCrossRef
59.
Verkuil, B., Brosschot, J. F., & Thayer, J. F. (2007). A sensitive body or a sensitive mind? Associations among somatic sensitization, cognitive sensitization, health worry, and subjective health complaints. Journal of Psychosomatic Research, 63(6), 673–681.PubMedCrossRef
60.
Bogaerts, K., Millen, A., Li, W., De Peuter, S., Van Diest, I., Vlemincx, E., et al. (2008). High symptom reporters are less interoceptively accurate in a symptom-related context. Journal of Psychosomatic Research, 65(5), 417–424.PubMedCrossRef
61.
Khasabov, S. G., Hamamoto, D. T., Harding-Rose, C., & Simone, D. A. (2007). Tumor-evoked hyperalgesia and sensitization of nociceptive dorsal horn neurons in a murine model of cancer pain. Brain Research, 1180, 7–19.PubMedCrossRef
62.
Straub, R. H., Wolff, C., Fassold, A., Hofbauer, R., Chover-Gonzalez, A., Richards, L. J., et al. (2008). Anti-inflammatory role of endorphins in osteoarthritis, rheumatoid arthritis, and adjuvant-induced polyarthritis. Arthritis Rheumatism, 58(2), 456–466.PubMedCrossRef
63.
Kroenke, K. (2007). Efficacy of treatment for somatoform disorders: A review of randomized controlled trials. Psychosomatic Medicine, 69(9), 881–888.PubMedCrossRef
64.
Creed, F., Tomenson, B., Guthrie, E., Ratcliffe, J., Fernades, L., Rigby, C., Read, N., & Thomson, D. G., (2009). On behalf of the North of Eangland IBS Research Group. Predictors of long term outcome in people with severe irritable syndrome who receive antidepressant or psychological treatment. Alimentary Pharmacology and Therapeutics (Submitted).
65.
Creed, F., Guthrie, E., Ratcliffe, J., Fernandes, L., Rigby, C., Tomenson, B., et al. (2005). Does psychological treatment help only those patients with severe irritable bowel syndrome who also have a concurrent psychiatric disorder? Australian and New Zealand Journal of Psychiatry, 39(9), 807–815.PubMedCrossRef
Metagegevens
Titel
Somatization is associated with physical health-related quality of life independent of anxiety and depression in cancer, glaucoma and rheumatological disorders
Auteurs
Thomas Hyphantis
Barbara Tomenson
Vassiliki Paika
Augoustina Almyroudi
Chrisavgi Pappa
Niki Tsifetaki
Paraskevi V. Voulgari
Alexandros A. Drosos
Nicholas Pavlidis
Francis Creed
Publicatiedatum
01-10-2009
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 8/2009
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-009-9527-6

Andere artikelen Uitgave 8/2009

Quality of Life Research 8/2009 Naar de uitgave

OriginalPaper

Health utility scores of colorectal cancer based on societal preference in Japan

OriginalPaper

Differential item functioning was negligible in an adaptive test of functional status for patients with knee impairments who spoke English or Hebrew

OriginalPaper

Development of a methodological PubMed search filter for finding studies on measurement properties of measurement instruments

Brief Communication

Prostate cancer-specific anxiety in Dutch patients on active surveillance: validation of the memorial anxiety scale for prostate cancer

OriginalPaper

Concordance of cancer patients’ function, symptoms, and supportive care needs

OriginalPaper

Agreement of patient and physician ratings on mobility and self-care in neurological diseases